News | October 29, 2013

Research on Central Venous Procedures Shows More Involvement by Radiologists

Evidence that radiologists inserting more central line catheters, medication ports and pumps have significant health system ramifications

October 29, 2013 — The findings of a Harvey L. Neiman Health Policy Institute study published online in the Journal of the American College of Radiology (JACR) confirm a major shift in practice at American hospitals regarding central venous procedures. What has traditionally been the domain of surgeons and anesthesiologists is being performed, in significantly larger numbers, by interventional radiologists, a change that the paper’s authors say has “profound health system implications.”

The Harvey L. Neiman Health Policy Institute paper, “Central Venous Access:  Evolving Roles of Radiology and other Specialties Nationally Over Two Decades,” was released online by the JACR earlier this year. The authors examined Medicare claims data from 1992 to 2011 for procedures involving central venous catheters and long-term central venous medical devices.

“This research should prompt health system leaders and administrators to re-evaluate the role of radiology departments in hospitals,” said Richard Duszak, M.D., FACR, CEO of the Neiman Institute and the paper’s lead author. “We’re seeing more radiology practices being displaced from long-standing hospital relationships because administrators think they can outsource all of their radiology needs. National data tells us, though, that radiologists are being relied upon with increasing frequency in the hospital setting to perform central venous procedures.”

The paper notes that the volume of central venous procedures among Medicare beneficiaries has grown significantly over the past two decades, with the number of long-term central venous device insertions increasing by 313 percent over that period. The researchers found that radiologists were once responsible for less than one percent of all long-term central venous devices, but now place over 48 percent of tunneled catheters and 27 percent of all medication ports. In all hospital settings combined, radiology departments are placing three of every four peripherally inserted central catheters.

“This study verifies a significant transition in the way central venous procedures are being handled in U.S. hospitals,” said Danny R. Hughes, Ph.D., one of the study’s authors. “Surgeons are stepping away from these functions and radiologists are filling the need. This tells us there is a direct tie between health policy and hospital administration decisions concerning radiology and patient access to these critical healthcare services.”

For more information:

Related Content

Teleflex Launches Next-Generation Sympro Elite and Expro Elite Snares
Technology | Cath Lab | February 07, 2018
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
SCAI Advocacy Committee Highlights Reimbursement Reform Efforts in 2017
News | Cath Lab | January 30, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) highlighted the efforts of its Advocacy Committee...
IAC Releases Cardiovascular Catheterization Accreditation Program
News | Cath Lab | January 25, 2018
January 25, 2018 – The Intersocietal Accreditation Commission (IAC) announced the release of its Cardiovascular Cathe
Videos | Cath Lab | January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab | January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab | November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab | November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab | November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab | November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Overlay Init